SpaceOAR Vue™ Hydrogel

Radiopaque Perirectal Spacer for Radiation Therapy

play icon
Edward Soffen, MD
SpaceOAR Vue Hydrogel
SpaceOAR Vue Hydrogel in applicator
SpaceOAR Vue Hydrogel being assembled
play icon
Edward Soffen, MD
SpaceOAR Vue Hydrogel
SpaceOAR Vue Hydrogel in applicator
SpaceOAR Vue Hydrogel being assembled
Edward Soffen, MD, speaks about SpaceOAR Vue Hydrogel.

SpaceOAR Vue Hydrogel is a new generation hydrogel spacer that offers enhanced visibility via CT scan, designed to help physicians improve contouring accuracy and consistently position patients receiving prostate cancer radiation, as compared to SpaceOAR™ Hydrogel.1

Key Resources

Advancing Radiation Therapy brochure Indications, Safety and Warnings Content on Demand and Events Patient Website Advancing Radiation Therapy
Request a Sales Rep Visit
you see it when you ct it

How it works 

SpaceOAR Vue Hydrogel, the next-generation hydrogel perirectal spacer is designed to offer enhanced visibility on CT. Due to the close proximity between the rectum and the prostate, radiation therapy can unintentionally cause rectal toxicity. SpaceOAR Vue Hydrogel is designed to help reduce the radiation delivered to the rectum during treatment.1​​
​

Why choose SpaceOAR Vue Hydrogel

The radiopacity is designed to improve the contouring accuracy during treatment plan creation, when compared to SpaceOAR Hydrogel.1

without spaceOAR
Reducing the need for a post-implant MRI may reduce the overall treatment costs per patient and the hospital staff’s time spent in obtaining reimbursement authorization1
rectum with spaceoar
The visibility of SpaceOAR Vue Hydrogel on a CT scan is designed to help reduce under- or over-contouring of the prostate and rectum for improved accuracy (when compared to SpaceOAR Hydrogel) and potentially more precise treatment planning1
rectum with radiation
Radiopacity may provide a suitable imaging option to MRI for patients with implanted metallic devices1

Benefits

optimization icon

Optimize dosing plan

Visibility of the gel on a CT scan designed to help to reduce under- or  over-contouring of the prostate and rectum for improved accuracy, as compared to SpaceOAR Hydrogel, and helps optimize treatment planning.1,2

streamline icon

Streamline workflow

Treatment planning can be done using CT only, reducing the need to acquire, reference and fuse MR and CT images to aid in visualization of the target region enabling appropriate patient positioning for radiation treatment using kV cone-beam CT.1

testing icon

Treat more patients

The radiopacity may provide a suitable imaging option to MRI for patients with implanted metallic devices.1

Ordering Information

ProductOrdering Information
SpaceOAR Vue SV-1010

 

Interested in learning more about SpaceOAR Vue Hydrogel?

Talk to a representative
SpaceOAR Vue Hydrogel

Refrences:

1. Data on file with Boston Scientific

Disclaimer:

SpaceOAR Vue Hydrogel is intended to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer and in creating this space it is the intent of SpaceOAR Vue Hydrogel to reduce the radiation dose delivered to the anterior rectum.

SpaceOAR Vue Hydrogel contains polyethylene glycol (PEG) and iodine.

Prior to using these devices, please review the Instructions for Use for a complete listing of indications, contraindications, warnings, precautions and potential adverse events.

As with any medical treatment, there are some risks involved with the use of SpaceOAR and SpaceOAR Vue Hydrogels. Potential complications associated with SpaceOAR and SpaceOAR Vue Hydrogels include, but are not limited to: pain associated with SpaceOAR and SpaceOAR Vue Hydrogels injection, pain or discomfort associated with SpaceOAR and SpaceOAR Vue Hydrogels, local inflammatory reactions, infection (including abscess), urinary retention, urgency, constipation (acute, chronic, or secondary to outlet obstruction), rectal tenesmus/muscle spasm, mucosal damage, ulcers, fistula, perforation (including prostate, bladder, urethra, rectum), necrosis, allergic reaction (localised or more severe reaction, such as anaphylaxis), embolism (venous or arterial embolism is possible and may present outside of the pelvis, potentially impacting vital organs or extremities), syncope and bleeding. ​

The occurrence of one or more of these complications may require treatment or surgical intervention.

CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings and instructions for use can be found in the product labelling supplied with each device. Information for use only in countries with applicable health authority registrations. This material not intended for use in France.

Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. Please check availability with your local sales representative or customer service

 

Top